Cataract Surgery With Intracameral Triamcinolone in Infants

The Use of Intraocular Triamcinolone in the Perioperative Period of Congenital Cataract Surgery

The aim of the present study is to investigate the outcomes of congenital cataract surgery when injecting intraoperative intracameral triamcinolone versus the postoperative use of oral prednisolone.

This is a prospective, randomized clinical trial. Sixty children will be submitted to congenital cataract surgery younger than 2 years of age. They will be randomly divided in two groups. The study group will receive an intraoperative intracameral triamcinolone acetonide injection. The control group will receive prednisolone syrup postoperatively. The surgical outcomes will be assessed after one year.

Inclusion Criteria:

• Patients younger than 2 years of age
• Unilateral or bilateral congenital cataracts compromising the red reflex

Exclusion Criteria:

• Corneal opacity
• Glaucoma
• Aniridia
• Subluxated cataract
• Traumatic cataract
• Complex microphthalmia
• Persistant hyperplastic primary vitreous
• Retinal detachment
• Patients with intraoperative complications, such as IOL implanted in the sulcus